share_log

关于国药集团财务有限公司2024年半年度风险持续评估的报告

Report on the 2024 semi-annual risk continuity assessment of Sinopharm Group Finance Co., Ltd.

SZSI ·  Aug 27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more